JP2021512910A5 - - Google Patents
Info
- Publication number
- JP2021512910A5 JP2021512910A5 JP2020542665A JP2020542665A JP2021512910A5 JP 2021512910 A5 JP2021512910 A5 JP 2021512910A5 JP 2020542665 A JP2020542665 A JP 2020542665A JP 2020542665 A JP2020542665 A JP 2020542665A JP 2021512910 A5 JP2021512910 A5 JP 2021512910A5
- Authority
- JP
- Japan
- Prior art keywords
- cocrystal
- powder
- proline
- ray diffractogram
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023173340A JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862627570P | 2018-02-07 | 2018-02-07 | |
| US62/627,570 | 2018-02-07 | ||
| PCT/US2019/016304 WO2019156907A1 (en) | 2018-02-07 | 2019-02-01 | Co-crystal forms of a novobiocin analog and proline |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173340A Division JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A Division JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021512910A JP2021512910A (ja) | 2021-05-20 |
| JP2021512910A5 true JP2021512910A5 (https=) | 2022-02-04 |
Family
ID=65444361
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542665A Pending JP2021512910A (ja) | 2018-02-07 | 2019-02-01 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2023173340A Withdrawn JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A Pending JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173340A Withdrawn JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A Pending JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10717755B2 (https=) |
| EP (1) | EP3749675B1 (https=) |
| JP (3) | JP2021512910A (https=) |
| KR (2) | KR102718111B1 (https=) |
| CN (2) | CN118894894A (https=) |
| AR (1) | AR114245A1 (https=) |
| AU (3) | AU2019217821B2 (https=) |
| BR (1) | BR112020016205A2 (https=) |
| CA (2) | CA3226385A1 (https=) |
| CL (2) | CL2020002051A1 (https=) |
| CO (1) | CO2020009761A2 (https=) |
| EA (1) | EA202091885A1 (https=) |
| IL (2) | IL276583B2 (https=) |
| MX (2) | MX2020008326A (https=) |
| MY (1) | MY209803A (https=) |
| PE (1) | PE20211446A1 (https=) |
| SG (1) | SG11202007530XA (https=) |
| TW (2) | TWI868593B (https=) |
| WO (1) | WO2019156907A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL276583B2 (en) | 2018-02-07 | 2025-03-01 | Reata Pharmaceuticals Inc | Crystal structures of proline and a novobiocin analog |
| CN119264211A (zh) | 2018-08-27 | 2025-01-07 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| CN115181146B (zh) * | 2021-04-02 | 2024-06-04 | 浙江普洛家园药业有限公司 | 一种新生霉素的提取工艺 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013006651A2 (pt) * | 2010-09-23 | 2017-07-18 | Nuformix Ltd | composição e cocristal de aprepitante l-prolina |
| TWI542596B (zh) * | 2011-05-09 | 2016-07-21 | 健生藥品公司 | （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體 |
| CN108640910A (zh) * | 2011-11-25 | 2018-10-12 | 诺弗米克斯技术有限公司 | 阿瑞吡坦l-脯氨酸溶剂化物-组合物和共晶体 |
| EP2602249B1 (en) * | 2011-12-06 | 2015-08-12 | F.I.S. Fabbrica Italiana Sintetici S.p.A. | Synthesis of rosuvastatin by means of co-crystals |
| WO2013119985A1 (en) * | 2012-02-09 | 2013-08-15 | University Of Kansas | C-terminal hsp90 inhibitors |
| ES2671478T3 (es) * | 2012-08-31 | 2018-06-06 | Novartis Ag | Derivados de 2'-etinil nucleósidos para el tratamiento de infecciones virales |
| TW201512201A (zh) * | 2013-03-14 | 2015-04-01 | Forum Pharmaceuticals Inc | 化合物的多晶型及鹽類 |
| CN106536498A (zh) * | 2014-06-24 | 2017-03-22 | 堪萨斯大学 | 作为hsp90抑制剂和hsp70诱导剂的具有经修饰醚基的联苯酰胺 |
| HUE052588T2 (hu) * | 2014-09-30 | 2021-05-28 | Jiangsu Hengrui Medicine Co | Az L-prolin/nátrium-glukóz kotranszporter 2 gátló kristály komplexének kristálya |
| IL276583B2 (en) | 2018-02-07 | 2025-03-01 | Reata Pharmaceuticals Inc | Crystal structures of proline and a novobiocin analog |
-
2019
- 2019-02-01 IL IL276583A patent/IL276583B2/en unknown
- 2019-02-01 EP EP19705879.5A patent/EP3749675B1/en active Active
- 2019-02-01 SG SG11202007530XA patent/SG11202007530XA/en unknown
- 2019-02-01 TW TW112106332A patent/TWI868593B/zh active
- 2019-02-01 BR BR112020016205-1A patent/BR112020016205A2/pt unknown
- 2019-02-01 US US16/265,256 patent/US10717755B2/en active Active
- 2019-02-01 KR KR1020207025571A patent/KR102718111B1/ko active Active
- 2019-02-01 KR KR1020247033920A patent/KR20240155354A/ko not_active Ceased
- 2019-02-01 CA CA3226385A patent/CA3226385A1/en active Pending
- 2019-02-01 WO PCT/US2019/016304 patent/WO2019156907A1/en not_active Ceased
- 2019-02-01 MY MYPI2020004057A patent/MY209803A/en unknown
- 2019-02-01 EA EA202091885A patent/EA202091885A1/ru unknown
- 2019-02-01 CN CN202410935084.1A patent/CN118894894A/zh active Pending
- 2019-02-01 IL IL315865A patent/IL315865A/en unknown
- 2019-02-01 CN CN201980011980.6A patent/CN112020506B/zh active Active
- 2019-02-01 PE PE2020001199A patent/PE20211446A1/es unknown
- 2019-02-01 CA CA3090646A patent/CA3090646C/en active Active
- 2019-02-01 AU AU2019217821A patent/AU2019217821B2/en active Active
- 2019-02-01 MX MX2020008326A patent/MX2020008326A/es unknown
- 2019-02-01 TW TW108104336A patent/TWI797249B/zh active
- 2019-02-01 JP JP2020542665A patent/JP2021512910A/ja active Pending
- 2019-02-05 AR ARP190100277A patent/AR114245A1/es unknown
-
2020
- 2020-06-05 US US16/894,461 patent/US11401294B2/en active Active
- 2020-08-06 MX MX2022012856A patent/MX2022012856A/es unknown
- 2020-08-06 CO CONC2020/0009761A patent/CO2020009761A2/es unknown
- 2020-08-07 CL CL2020002051A patent/CL2020002051A1/es unknown
-
2022
- 2022-12-05 AU AU2022283638A patent/AU2022283638B2/en active Active
- 2022-12-27 CL CL2022003784A patent/CL2022003784A1/es unknown
-
2023
- 2023-02-13 US US18/168,495 patent/US20240043465A1/en not_active Abandoned
- 2023-10-05 JP JP2023173340A patent/JP2024001167A/ja not_active Withdrawn
-
2024
- 2024-10-25 AU AU2024227646A patent/AU2024227646A1/en active Pending
-
2025
- 2025-10-23 JP JP2025178611A patent/JP2026012851A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI839461B (zh) | Il-17a調節物及其用途 | |
| EP1670757B1 (en) | Pyrrole and pyrazole derivatives as potentiators of glutamate receptors | |
| TWI299991B (en) | Cetp inhibitors | |
| EP3022202B1 (en) | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core | |
| KR101424013B1 (ko) | 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산의 결정형과 그의 제조방법 | |
| US20210052585A1 (en) | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same | |
| JP2021512910A5 (https=) | ||
| TW201418218A (zh) | 部份飽和的含氮雜環化合物 | |
| KR20220054293A (ko) | Isoqc 및/또는 qc 효소의 억제제로서 n-치환된-3,4-(융합된 5-환)-5-페닐-피롤리딘-2-온 화합물 | |
| WO2017048962A1 (en) | Hepatitis b core protein modulators | |
| US20070088165A1 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
| EP3612520B1 (en) | Isoxazole derivatives as nuclear receptor agonists and uses thereof | |
| JP2023541434A5 (https=) | ||
| TW201617316A (zh) | 人類免疫不全症病毒複製之抑制物 | |
| WO2013019653A1 (en) | Compounds and methods | |
| TW201536743A (zh) | Ｍｄｍ２抑制劑之製備方法及結晶型 | |
| JP6208212B2 (ja) | 呼吸器疾患用薬 | |
| US20080015237A1 (en) | New compounds i/418 | |
| US11155537B2 (en) | Crystal of benzofuran derivative free base and preparation method | |
| US20140288040A1 (en) | Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection | |
| JP2021536505A5 (https=) | ||
| TW200404802A (en) | Xanthine phosphodiesterase V inhibitor polymorphs | |
| JP7158464B2 (ja) | カリウムチャネル阻害剤としての置換ベンゾイミダゾール | |
| US11447470B2 (en) | Pyrimidinone-containing compound, preparation method thereof, pharmaceutical composition and application thereof | |
| JP6758374B2 (ja) | Ｉｄｈ２突然変異を標的とする抗腫瘍化合物及びその使用方法 |